Robotic platforms for endometrial cancer treatment: review of the literature
Künye
Gungorduk K, Kahramanoglu O, Ozdemir IA, Kahramanoglu I. Robotic platforms for endometrial cancer treatment: review of the literature. Minerva Med. 2021 Feb;112(1):47-54. doi: 10.23736/S0026-4806.20.07053-6. PMID: 33586397.Özet
Introduction: The cornerstone in the management of endometrial cancer (EC) is surgical staging. Over the last few decades, minimally invasive surgery has been widely accepted as a mainstay in the treatment of endometrial cancer. The first robotic-assisted gynecological surgery was performed in 1998.
Evidence acquisition: The literature search was conducted using MEDLINE, EMBASE and PUBMED databases from January 1998 to September 2020.
Evidence synthesis: Several studies have reported the advantages of robotic-assisted surgery over laparoscopy in the management of EC. These are most pronounced in obese patients. Robotic-assisted surgery is also associated with a shorter learning curve, particularly for lymphadenectomy, which enables more surgeons to perform minimally invasive surgery for EC.
Conclusions: The effectiveness and oncological results of robotic surgery for EC appear to be similar to those of other surgical methods, but fewer intraoperative complications occur than with other methods.
Kaynak
Minerva MedicaCilt
112Sayı
1Bağlantı
https://pubmed.ncbi.nlm.nih.gov/33586397/https://www.minervamedica.it/en/journals/minerva-medica/article.php?cod=R10Y2021N01A0047&acquista=1
https://hdl.handle.net/20.500.12809/8970